Patents by Inventor Swati Ajay Piramal
Swati Ajay Piramal has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20220023263Abstract: The present invention relates to the pyrrolidine substituted with flavone derivatives, represented by the compounds of Formula (I) or a pharmaceutically acceptable salt, a solvate, a stereoisomer or a diastereoisomer thereof for use in the treatment of cancers associated with human papillomavirus. The present invention also relates to the pharmaceutical compositions containing the compounds of Formula (I) for the treatment of cancers associated with human papillomavirus.Type: ApplicationFiled: September 29, 2021Publication date: January 27, 2022Applicant: Piramal Enterprises LimitedInventors: Swati Ajay PIRAMAL, Muralidhara Padigaru, Veena R. Agarwal, Gandhali Ashwin Deshpande
-
Patent number: 11160789Abstract: The present invention relates to the pyrrolidine substituted with flavone derivatives, represented by the compounds of Formula (I) or a pharmaceutically acceptable salt, a solvate, a stereoisomer or a diastereoisomer thereof for use in the treatment of cancers associated with human papillomavirus. The present invention also relates to the pharmaceutical compositions containing the compounds of Formula (I) for the treatment of cancers associated with human papillomavirus.Type: GrantFiled: April 9, 2020Date of Patent: November 2, 2021Assignee: PIRAMAL ENTERPRISES LIMITEDInventors: Swati Ajay Piramal, Muralidhara Padigaru, Veena R. Agarwal, Gandhali Ashwin Deshpande
-
Publication number: 20200289465Abstract: The present invention relates to the pyrrolidine substituted with flavone derivatives, represented by the compounds of Formula (I) or a pharmaceutically acceptable salt, a solvate, a stereoisomer or a diastereoisomer thereof for use in the treatment of cancers associated with human papillomavirus. The present invention also relates to the pharmaceutical compositions containing the compounds of Formula (I) for the treatment of cancers associated with human papillomavirus.Type: ApplicationFiled: April 9, 2020Publication date: September 17, 2020Applicant: Piramal Enterprises LimitedInventors: Swati Ajay PIRAMAL, Muralidhara PADIGARU, Veena R. AGARWAL, Gandhali Ashwin DESHPANDE
-
Patent number: 10688079Abstract: The present invention relates to the pyrrolidine substituted with flavone derivatives, represented by the compounds of Formula (I) or a pharmaceutically acceptable salt, a solvate, a stereoisomer or a diastereoisomer thereof for use in the treatment of cancers associated with human papillomavirus. The present invention also relates to the pharmaceutical compositions containing the compounds of Formula (I) for the treatment of cancers associated with human papillomavirus.Type: GrantFiled: September 7, 2018Date of Patent: June 23, 2020Assignee: Piramal Enterprises LimitedInventors: Swati Ajay Piramal, Muralidhara Padigaru, Veena R. Agarwal, Gandhali Ashwin Deshpande
-
Publication number: 20180369200Abstract: The present invention relates to the pyrrolidine substituted with flavone derivatives, represented by the compounds of Formula (I) or a pharmaceutically acceptable salt, a solvate, a stereoisomer or a diastereoisomer thereof for use in the treatment of cancers associated with human papillomavirus. The present invention also relates to the pharmaceutical compositions containing the compounds of Formula (I) for the treatment of cancers associated with human papillomavirus.Type: ApplicationFiled: September 7, 2018Publication date: December 27, 2018Applicant: Piramal Enterprises LimitedInventors: Swati Ajay Piramal, Muralidhara Padigaru, Veena R. Agarwal, Gandhali Ashwin Deshpande
-
Patent number: 10098869Abstract: The present invention relates to the pyrrolidine substituted with flavone derivatives, represented by the compounds of Formula (I) or a pharmaceutically acceptable salt, a solvate, a stereoisomer or a diastereoisomer thereof for use in the treatment of cancers associated with human papillomavirus. The present invention also relates to the pharmaceutical compositions containing the compounds of Formula (I) for the treatment of cancers associated with human papillomavirus.Type: GrantFiled: August 8, 2016Date of Patent: October 16, 2018Assignee: PIRAMAL ENTERPRISES LIMITEDInventors: Swati Ajay Piramal, Muralidhara Padigaru, Veena R. Agarwal, Gandhali Ashwin Deshpande
-
Publication number: 20170189378Abstract: The present invention relates to the pyrrolidine substituted with flavone derivatives, represented by the compounds of Formula (I) or a pharmaceutically acceptable salt, a solvate, a stereoisomer or a diastereoisomer thereof for use in the treatment of cancers associated with human papillomavirus. The present invention also relates to the pharmaceutical compositions containing the compounds of Formula (I) for the treatment of cancers associated with human papillomavirus.Type: ApplicationFiled: August 8, 2016Publication date: July 6, 2017Inventors: Swati Ajay Piramal, Muralidhara Padigaru, Veena R. Agarwal, Gandhali Ashwin Deshpande
-
Publication number: 20160296577Abstract: The present invention relates to a standardised extract of Momordica Charantia containing one or more nitrogen containing heterocyclic compounds as the bioactive markers and a process for the preparation thereof. Tile present invention also relates to a composition comprising the standardised extract of Momordica Charantia containing one or more nitrogen containing heterocyclic compounds as the bioactive markers. The present invention also relates to use of the standardised extract of Momordica Charantia or the composition containing the said standardised extract for the treatment of metabolic disorders such as diabetes.Type: ApplicationFiled: October 28, 2014Publication date: October 13, 2016Applicant: PIRAMAL ENTERPRISES LIMITEDInventors: Swati Ajay PIRAMAL, Ashish Chandrakant SUTHAR, Rahul Ramesh SHELAR
-
Publication number: 20140142159Abstract: The present invention relates to the pyrrolidine substituted with flavone derivatives, represented by the compounds of Formula (I) or a pharmaceutically acceptable salt, a solvate, a stereoisomer or a diastereoisomer thereof for use in the treatment of cancers associated with human papillomavirus. The present invention also relates to the pharmaceutical compositions containing the compounds of Formula (I) for the treatment of cancers associated with human papillomavirus.Type: ApplicationFiled: June 22, 2012Publication date: May 22, 2014Applicant: PIRAMAL ENTERPRISES LIMITEDInventors: Swati Ajay Piramal, Muralidhara Padigaru, Veena R Agarwal, Gandhali Ashwin Deshpande
-
Patent number: 8182843Abstract: The present invention relates to bioadhesive compositions for oral application, which comprise a curcuminoid substance as an active ingredient. The present invention also relates to method of using said bioadhesive composition for the prevention and treatment of periodontal diseases such as gingivitis and other periodontal diseases.Type: GrantFiled: June 29, 2007Date of Patent: May 22, 2012Assignee: Piramal Life Sciences LimitedInventors: Swati Ajay Piramal, Shripad Rhushikesh Jathar, Rajesh Prabhamal Sirwani, Prakash Malhotra
-
Patent number: 7914824Abstract: The present invention relates to the use of standardized extract of Tinospora cordifolia as an immunoadjuvant in the treatment of renal disorders such as nephrotic syndrome and chronic recurrent urinary tract infections, both complicated and uncomplicated. The present invention also relates to pharmaceutical compositions comprising the standardized extract of Tinospora cordifolia. The present invention further relates to a method of treatment of renal disorders such as recurrent urinary tract infection particularly occurring due to relapsing E. coli, Klebsiella and other gram negative infections and to a method of treatment of nephrotic syndrome using standardized extract of Tinospora cordifolia as an immunoadjuvant in conjunction with conventional therapy.Type: GrantFiled: April 4, 2005Date of Patent: March 29, 2011Assignee: Piramal Life Sciences LimitedInventors: Vidya Narayan Acharya, Triptikumar Mukhopadhyay, Swati Ajay Piramal
-
Publication number: 20090297644Abstract: The present invention relates to bioadhesive compositions for oral application, which comprise a curcuminoid substance as an active ingredient. The present invention also relates to method of using said bioadhesive composition for the prevention and treatment of periodontal diseases such as gingivitis and other periodontal diseases.Type: ApplicationFiled: June 29, 2007Publication date: December 3, 2009Applicant: PIRAMAL LIFE SCIENCES LIMITEDInventors: Swati Ajay Piramal, Shripad Rhushikesh Jathar, Rajesh Prabhamal Sirwani, Prakash Malhotra
-
Publication number: 20080274212Abstract: The present invention relates to the use of standardized extract of Tinospora cordifolia as an immunoadjuvant in the treatment of renal disorders such as nephrotic syndrome and chronic recurrent urinary tract infections, both complicated and uncomplicated. The present invention also relates to pharmaceutical compositions comprising the standardized extract of Tinospora cordifolia. The present invention further relates to a method of treatment of renal disorders such as recurrent urinary tract infection particularly occurring due to relapsing E. coli, Klebsiella and other gram negative infections and to a method of treatment of nephrotic syndrome using standardized extract of Tinospora cordifolia as an immunoadjuvant in conjunction with conventional therapy.Type: ApplicationFiled: April 4, 2005Publication date: November 6, 2008Applicant: NICHOLAS PIRAMAL INDIA LIMITEDInventors: Vidya Narayan Acharya, Triptikumar Mukhopadhyay, Swati Ajay Piramal
-
Patent number: 7404962Abstract: A combination kit for the treatment of malaria caused by Plasmodium vivax (P. vivax) having individual doses of an anti-malarial agent, 3-[1-[[4-[(6-methoxy-8-quinolinyl)amino]pentyl]amino]ethylidene]-dihydro-2(3H)-furanone (I) in the form of capsules; individual doses of the anti-malarial agent, chloroquine in the form of tablets; and instruction material for the administration of the two anti-malarial drugs. The combination kit is particularly suited for a 6 days treatment regimen where the treatment is rendered by five tablets containing 500 mg of chloroquine phosphate (equivalent to 300 mg base), three to be taken on day one and one each on days two and three; and five capsules containing 25 mg of 3-[1-[[4-[(6-methoxy-8-quinolinyl)amino]pentyl]amino]ethylidene]-dihydro-2(3H)-furanone (I), one each to be taken on days two to six.Type: GrantFiled: August 30, 2000Date of Patent: July 29, 2008Assignees: Nicholas Piramal India Limited, Council of Scientific and Industrial ResearchInventors: Francis Joseph Pinto, Swati Ajay Piramal, Ram Pratap, Amiya Prasad Bhaduri, Harsh Pati Thapliyal, Sunil Kumar Puri, Guru Prasad Dutta, Anil Kumar Dwivedi, Satyawan Singh, Pratima Srivastava, Vikash Chandra Pandey, Sudhir Srivastava, Shio Kumar Singh, Ram Chandra Gupta, Jagdishwar Sahai Srivastava, Omkar Prasad Asthana